BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Drug Development

  Ark Therapeutics Release: EG011 (Refractory Angina) Demonstrates Ability To Grow New Blood Vessels And Restore Heart Function Following Heart Attack

  June 19, 2008

   · 

  8 min read
• Policy

  Eurand Receives Approvable Letter From FDA for EUR-1008 (Zentase)

  June 19, 2008

   · 

  5 min read
• Policy

  Discovery Laboratories Delays Surfaxin Response to FDA

  June 19, 2008

   · 

  7 min read
• FDA

  ThermoGenesis Announces Receipt of CE Mark for MarrowXpress(TM)

  June 19, 2008

   · 

  4 min read
• Business

  Calypte Biomedical Corporation Appoints Donald Taylor as CEO

  June 19, 2008

   · 

  5 min read
• Drug Development

  Forest Laboratories, Inc. Anti-infective Hits Main Goal in Studies

  June 19, 2008

   · 

  5 min read
• Drug Development

  Sepracor, Inc. Epilepsy Drug Cuts Seizures in Studies

  June 19, 2008

   · 

  6 min read
• FDA

  Perrigo Company Announces Approval for Rx Cetirizine Syrup

  June 19, 2008

   · 

  2 min read
• Business

  Cell Therapeutics, Inc. to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data

  June 19, 2008

   · 

  1 min read
• Genetown

  PAREXEL International Enhances Early Phase Clinical Development Offering for Central Nervous System Studies

  June 19, 2008

   · 

  5 min read